CollPlant Ltd.
CollPlant Ltd. (CollPlant) is a biotechnology company. It is engaged in development manufacture and marketing of the collagen biomaterials for the wound care and orthopedic markets. It develops plant-derived collagens, which are used in medical products including bone growth matrices, facial aesthetics, wound dressings, hemostats and sealants. The product portfolio of the company incldue recombinant human type I heterotrimeric atelocollagen, collagen matrix, collagen-based wound dressings, polymer composites and protein-based biomaterials. In addition, CollPlant is developing a pipeline of plant-derived protein polymers and composites used in orthopedics, aesthetic medicine, urinary incontinence and wound healing applications. CollPlant is headquartered in Ness-Ziona, Israel.
Recently, the company signed an agreement with Edwards Lifesciences Corporation, a developer of products and technologies to treat advanced cardiovascular diseases, for the joint development of prototypes of two proprietary collagen-based cardiovascular products.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

